Concepedia
Statistics
Publications
21
Citations
944
H-Index
15
Active since
2012
Affiliations
Fondazione IRCCS Istituto Nazionale dei Tumori(Current)
Hôpital Paul-Brousse
Inserm
Assistance Publique – Hôpitaux de Paris
University of Verona
Pamela Biondani is an author at Fondazione IRCCS Istituto Nazionale dei Tumori specializing in medicine, oncology, and pathology.
Top concepts
MedicineOncologyPathologyColorectal CancerRadiation OncologyPharmacologyCancer TherapyHepatologyCancer ResearchSurgical Oncology
Publications per year
2012–2024
Crizotinib Therapy for Advanced Lung Adenocarcinoma and a <i>ROS1</i> Rearrangement: Results From the EUROS1 Cohort
Julien Mazières, Gérard Zalcman, Lucio Crinò et al. · Journal of Clinical Oncology · 2015 · 348 citations · Full text
Activity of temozolomide in patients with advanced chemorefractory colorectal cancer and MGMT promoter methylation
Filippo Pietrantonio, Federica Perrone, Filippo de Braud et al. · Annals of Oncology · 2013 · 79 citations
Mgmt Promoter Methylation, Medicine, Pharmacology +4
Everolimus in combination with octreotide long‐acting repeatable in a first‐line setting for patients with neuroendocrine tumors: An ITMO group study
Emilio Bajetta, Laura Catena, Nicola Fazio et al. · Cancer · 2014 · 74 citations
Safety of an anti-PD-1 immune checkpoint inhibitor in a liver transplant recipient
Pamela Biondani, Eléonora De Martin, Didier Samuel · Annals of Oncology · 2017 · 60 citations
Transplant Rejection, Translational Medicine, Transplantation +12
Activity of EGFR Tyrosine Kinase Inhibitors in NSCLC With Refractory Leptomeningeal Metastases
Ronan Flippot, Pamela Biondani, Édouard Auclin et al. · Journal of Thoracic Oncology · 2019 · 36 citations · Full text
Medicine, Receptor Tyrosine Kinase, Refractory Leptomeningeal Metastases +4
1–5 of 21